You just read:

-- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes

News provided by

Neurocrine Biosciences, Inc.

Jun 17, 2010, 06:00 ET